Frequently Asked Questions

Open all FAQs

About this Research Study:

The ASPECT Study is looking for participants to evaluate the safety and effectiveness of an investigational drug for agitation associated with Alzheimer’s dementia.  In order to be eligible for this study, a potential participant must:

  • Be between the ages of 50 and 90 [inclusive]
  • Have a diagnosis of probable Alzheimer’s dementia
  • Have moderate-to-severe agitation that interferes with their daily life
  • Have a reliable carer who spends a minimum of 2 hours per day, 4 days per week with them and is willing and able to comply with all study procedures

     

There are additional criteria that are included in the questionnaire on this website and some that are reviewed by the study team at the study site at the first appointment.

The ASPECT Study involves attending study appointments, completing study procedures, taking the study drug (investigational drug or placebo) and reporting on the participant’s behaviours.  

This initial appointment is an opportunity for you to:

  • Learn more about the ASPECT Study. You’ll be speaking to a study coordinator at the study site to learn more regarding your participation in this study.

  • Ask any important questions you may have. These can be any questions you may have about this study or clinical research in general.

  • Determine if the ASPECT Study may be right for you. After speaking to the study coordinator and learning details about this study, the research staff will evaluate whether you pre-qualify to participate. If you pre-qualify, you will be given an opportunity to decide if participation is right for you. If you agree to take part, the site will ask you to review and sign a consent form.

If qualified, participation can last up to 20 weeks, with up to 10 appointments with the study site. The study coordinator can answer any questions you have about the ASPECT Study.

The investigational drug being studied in the ASPECT Study is a capsule taken orally.

A placebo is a substance with no active drug.  In this case, the placebo looks like the investigational drug but does not contain the active ingredient.

Do not discontinue any medication unless you are advised to do so by the study site staff or your GP.

The health and safety of study participants are always the top priority of clinical research study centres. The precautions taken may vary by study centre.

The study sites are located throughout the United Kingdom.

There is no cost to you for participating in this study.  If you qualify for this study, study-related care will be provided at no cost to you and participants may be compensated for their time.

Research studies are designed in specific ways to test the investigational drug for safety and effectiveness. One or more of the answers that you provided were outside of the eligibility criteria for this study. This does not mean you will not qualify for different research studies.

About Research Studies:

A research study (also known as a clinical trial) is a medical study that is designed to answer questions about the safety and efficacy of potential new drugs and to find out how well they work. These studies must be performed before a potential new medication or treatment can be approved for use in patients and sold to the general public.  

It is important to test drugs and medical products in the people they are meant to help. It is also important to conduct research in a variety of people, because each individual may respond differently to treatments. 

For each research study, researchers develop eligibility criteria, such as age, gender, previous treatment history and other medical conditions. Not everyone who applies for a research study will be accepted. Participants will be selected based on the eligibility criteria and the number of participants needed by the researchers.

Research studies are used to test medications before they are sold to the general public. The testing that takes place during the studies provides information regarding the safety and effectiveness of the potential medication. 

One way to find information about clinical trials is by searching this website: eudract.ema.europa.eu eudract.ema.europa.eu is the European database for all interventional clinical trials. It is the European database for all interventional clinical trials on medicinal products authorised in the European Union (EEA) and outside the EU/EEA. Protocol and results information on interventional clinical trials have been publicly available through the European Union Clinical Trials Register since September 2011.

For those who are qualified, taking part in research studies offers benefits:

  • Getting actively involved in their own healthcare
  • Helping others by contributing to medical research


It is important to test drugs and medical products in the people they are meant to help. It is also important to conduct research in a variety of people, because each individual may respond differently to treatments. 

For each research study, researchers develop eligibility criteria, such as age, gender, previous treatment history and other medical conditions. Not everyone who applies for a research study will be accepted. Volunteers may be excluded based on the eligibility criteria and/or the number of participants needed by the researchers.

Research studies can be sponsored by an organisation such as a pharmaceutical company, a patient advocacy organisation or an individual, such as a doctor or healthcare provider. The sponsor determines the location(s) of the trials, which are usually conducted at universities, medical centres, clinics, doctors’ offices and/or at hospitals.

The government requires researchers to give prospective participants complete and accurate information about what will happen during the study. Participants must sign an “informed consent” form before joining the study, indicating they understand that the study is research and that they can leave the research study at any time. This informed consent helps ensure that a prospective research study participant understands what is involved.

Your choice regarding cookies on this site

We use cookies to optimise site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies, which can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.